A PHASE II STUDY WITH ADDITIONAL INTRAPERITONEAL CISPLATIN/ETOPOSIDE TO FIRST-LINE CHEMOTHERAPY FOR ADVANCED OVARIAN CANCER IN DEVELOPING COUNTRY: A SHANGHAI GYNECOLOGIC ONCOLOGY GROUP AICE TRIAL

2016 ◽  
Author(s):  
Rong Jiang
Keyword(s):  
Ovarian Cancer ◽  
Developing Country ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Gynecologic Oncology ◽  
Advanced Ovarian Cancer ◽  
Gynecologic Oncology Group ◽  
Oncology Group ◽  
First Line ◽  
Line Chemotherapy

Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study

2006 ◽  
Vol 103 (2) ◽  
pp. 523-526 ◽  
Author(s):  
Paula M. Fracasso ◽  
John A. Blessing ◽  
Kelly L. Molpus ◽  
Lisa M. Adler ◽  
Joel I. Sorosky ◽  
...  
Keyword(s):  
Endometrial Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Second Line ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

A Gynecologic Oncology Group Phase II Study of Amonafide (NSC 308847) in Epithelial Ovarian Cancer

1993 ◽  
Vol 16 (6) ◽  
pp. 529-531 ◽  
Author(s):  
Robert F. Asbury ◽  
John A. Blessing ◽  
Katherine Y. Look ◽  
Daniel Clarke-Pearson ◽  
Howard D. Homesley
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Oncology Group
Sign in / Sign up

Export Citation Format

Share Document